<div class="content-intro"><p></p> <div data-ogsc="black"><span data-ogsc="" data-ogsb="yellow"><strong data-ogsc="" data-olk-copy-source="MessageBody">.
Our commercial portfolio includes the first and only FDA-approved treatments for Parkinson’s disease psychosis and Rett syndrome.
We are developing the next wave of therapeutic advancements with a robust and diverse pipeline that includes mid- to late-stage programs in Alzheimer’s disease psychosis and Lewy body dementia psychosis, along with earlier-stage programs that address other underserved patient needs.
At Acadia, we’re here to be their difference.
</span></div></div><p><strong><u>Position Summary</u></strong></p> <p>The Senior Manager/Associate Director, Commercial Operations will play a key role in preparing Acadia Pharmaceuticals Germany for the successful launch of a new rare disease product for Rett syndrome.
This role will support commercial strategy, launch readiness, cross-functional execution, and performance tracking to identify, implement, and measure business opportunities in the German market.
</p> <p><strong><u>Primary.